Condition: Diabetic Macular Edema (DME) · Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
The goal of this study is to evaluate the safety and efficacy of LX111 treatment of DME. This study will enroll participants aged ≥ 18 vears old to receive a single unilateral intravitreal (lVT) injection of LX111 to evaluate its safety and efficacy.
This description comes directly from the study's public registry record.
Li Su · +86 02136126254 · li.su@shgh.cn
Always discuss trial participation with your own doctor first.
| Shanghai General Hospital | Shanghai, China | Recruiting |
| Zhongshan Hospital | Shanghai, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07362927